Patent US4187286A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4187286A Expired / Lapsed US ⏱️ 0.0 years remaining

Contraceptive suppository

Assignee: G and W Laboratories Inc
•
Filing: 1979-01-02
•
Granted: 1980-02-05
•
Expires: 1999-01-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A suppository especially adapted for vaginal insertion to act as a contraceptive which comprises a mixture of polyethylene glycol, a spermicidally-active ingredient, a thickening agent, an effervescent agent and alginic acid, the action of the alginic acid reacting with the effervescent agent in moist conditions to form carbon dioxide and also forming a viscous barrier adherent to the vaginal walls to prevent penetration of the sperm.

Inventors

  • 👤 Bertram J. Marcus

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 09:23
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0034; Y; Y10; Y10S; Y10S424/00; Y10S424/14

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 92 words
A suppository consisting essentially of polyethylene glycol, a thickening agent, alginic acid, an effervescent agent and a medicinally active ingredient, the polyethylene glycol being present in a proportion of about 61.2-74.8 percent by weight, the thickening agent being present in a proportion of about 0.9-1.1 percent by weight, the effervescent agent being present in a proportion of about 10.8-13.2 percent by weight, the alginic acid being present in a proportion of about 13.5-16.5 percent by weight, and the medicinally active ingredients being present in a proportion of about 3.6-4.4 percent by weight.
Claim 2
Dependent Claim 92 words
A suppository consisting essentially of polyethylene glycol, a thickening agent, alginic acid, an effervescent agent and a medicinally active ingredient, the polyethylene glycol being present in a proportion of about 61.2-74.8 percent by weight, the thickening agent being present in a proportion of about 0.9-1.1 percent by weight, the effervescent agent being present in a proportion of about 10.8-13.2 percent by weight, the alginic acid being present in a proportion of about 13.5-16.5 percent by weight, and the medicinally active ingredients being present in a proportion of about 3.6-4.4 percent by weight.
Claim 3
Dependent Claim 41 words
The suppository of claim 1 wherein the polyethylene glycol is a mixture of at least two different molecular weight polyethylene glycols, one having a molecular weight of about 300 and at least one other having a molecular weight of about 1000.
Claim 4
Dependent Claim 30 words
The suppository of claim 1 wherein the thickening agent is a member of the group consisting of microcrystalline cellulose, methyl cellulose, carboxymethyl cellulose, polyvinyl pyrrolidone, sodium alginate, and mixtures thereof.
Claim 5
Dependent Claim 22 words
The suppository of claim 1 wherein the effervescent agent is a member of the group consisting of sodium bicarbonate and potassium biphosphate.
Claim 6
Dependent Claim 13 words
The suppository of claim 1 wherein the medicinally active agent is a spermicide.
Claim 7
Dependent Claim 10 words
The suppository of claim 5 wherein the spermicide is nonoxynol-9.
Claim 8
Dependent Claim 10 words
The suppository of claim 1 wherein the suppository is vaginally-insertable.
Claim 9
Dependent Claim 10 words
The suppository of claim 1 wherein the suppository is rectally-insertable.
Claim 10
Dependent Claim 21 words
The suppository of claim 8 wherein the medicinally-acitve ingredients are selected from the group consisting of bisacodyl, aminophylline, acetaminophen and aspirin.
Claim 11
Dependent Claim 26 words
The suppository of claim 1 wherein the alginic acid and the effervescent agent together comprise about 24.3 to about 29.7 percent by weight of the composition.

References Cited (Backward Citations)

US1878766A Cited
US2191139A Cited
US2584166A Cited
US2623839A Cited
US2623840A Cited
US2623841A Cited
US3062715A Cited
US3234091A Cited
US2854377A Cited
US3121663A Cited
USRE29102E Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-02-04 1983-08-06 1984-02-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-02-04 1987-08-06 1988-02-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-02-04 1991-08-06 1992-02-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag